Migraine affects approximately 1.3 billion people worldwide, representing a large-scale public health problem. Despite the high number of those affected, this neurological condition continues to be frequently trivialized.
The article is authored by Sofia Campina, Rita Brás and Sara Regalo, who are part of the Cutaneous Allergies Interest Group of the Portuguese Society of Allergology and Clinical Immunology.
The trivialization of migraine frequently results in a lack of adequate recognition of the severity of the condition by health professionals and society in general, affecting patients' quality of life.



